Research Database

23 studies found

Positive

82.6%

Negative

0.0%

Inconclusive

17.4%

Page 1 of 2

PositiveAnimal Study -

Fermented seaweed extracts ameliorate diabetic nephropathy in streptozotocin-induced diabetic rats via PI3K/AKT/mTOR pathway

2025

DiabetesDiabetic Kidney DiseaseInflammation+2

PositiveAnimal Study -

Immunomodulatory function of cannabinoid receptor 2 and its agonist osteogenic growth peptide in health and cancer: a study in mice and humans

2025

Arthritis

InconclusiveAnimal Study -

Blockade of cannabinoid CB<sub>1</sub> receptors potentiates the anti‐fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy

2025

Diabetes

InconclusiveAnimal Study - Veterinary Clinical Trial

The Identification of Novel Anti-Inflammatory Effects of Cannabigerol in the Kidney Tissue of Rats Subjected to a High-Fat High-Sucrose Diet

2025

Chronic Kidney Disease

PositiveAnimal Study - Veterinary Clinical Trial

Resolvin E1 heals injured cardiomyocytes: Therapeutic implications and H-FABP as a readout for cardiovascular disease & systemic inflammation

2023

Cardiovascular Diseases (CVD)

PositiveMeta-analysis -

Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis

2022

Diabetic Kidney Disease

InconclusiveReview/Other

A New Clinical Utility for Tubular Markers to Identify Kidney Responders to Saxagliptin Treatment in Adults With Diabetic Nephropathy

2021

Diabetes

PositiveDouble Blind Clinical Trial

Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized Controlled Trial

2021

Diabetes

PositiveAnimal Study -

(+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB 1 R antagonist/CB 2 R agonist that prevents diabetic nephropathy in mice

2021

Diabetes

PositiveReview/Other

Nephrologist Views Regarding Cannabinoid Use in Advanced Chronic Kidney Disease and Dialysis: A Survey

2021

Cancer

InconclusiveReview/Other

The nephrologist's guide to cannabis and cannabinoids

2020

Chronic Kidney Disease

PositiveReview/Other

The effects of delta-9-tetrahydrocannabinol on Krüppel-like factor-4 expression, redox homeostasis, and inflammation in the kidney of diabetic rat

2019

Diabetes

PositiveReview/Other

A Novel Standardized Cannabis sativa L. Extract and Its Constituent Cannabidiol Inhibit Human Polymorphonuclear Leukocyte Functions

2019

Inflammation

PositiveReview/Other

The role of cannabinoid signaling in acute and chronic kidney diseases

2018

Chronic Kidney Disease

PositiveReview/Other

Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy.

2017

Diabetic Kidney Disease

PositiveDouble Blind Clinical Trial

Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease

2016

Diabetes

PositiveReview/Other

Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case-control study

2016

Chronic Kidney Disease

PositiveReview/Other

The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases.

2015

Chronic Kidney Disease

PositiveReview/Other

Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy.

2012

Diabetic Kidney Disease

PositiveReview/Other

Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria

2012

Diabetes

Command Palette

Research Database

Fermented seaweed extracts ameliorate diabetic nephropathy in streptozotocin-induced diabetic rats via PI3K/AKT/mTOR pathway

Immunomodulatory function of cannabinoid receptor 2 and its agonist osteogenic growth peptide in health and cancer: a study in mice and humans

Blockade of cannabinoid CB<sub>1</sub> receptors potentiates the anti‐fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy

The Identification of Novel Anti-Inflammatory Effects of Cannabigerol in the Kidney Tissue of Rats Subjected to a High-Fat High-Sucrose Diet

Resolvin E1 heals injured cardiomyocytes: Therapeutic implications and H-FABP as a readout for cardiovascular disease & systemic inflammation

Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis

A New Clinical Utility for Tubular Markers to Identify Kidney Responders to Saxagliptin Treatment in Adults With Diabetic Nephropathy

Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized Controlled Trial

(+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB 1 R antagonist/CB 2 R agonist that prevents diabetic nephropathy in mice

Nephrologist Views Regarding Cannabinoid Use in Advanced Chronic Kidney Disease and Dialysis: A Survey

The nephrologist's guide to cannabis and cannabinoids

The effects of delta-9-tetrahydrocannabinol on Krüppel-like factor-4 expression, redox homeostasis, and inflammation in the kidney of diabetic rat

A Novel Standardized Cannabis sativa L. Extract and Its Constituent Cannabidiol Inhibit Human Polymorphonuclear Leukocyte Functions

The role of cannabinoid signaling in acute and chronic kidney diseases

Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy.

Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case-control study

The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases.

Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy.

Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria